Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


InterMed Discovery/Biotropics in equity deal

The German natural product lead-discovery company, Intermed Discovery (IMD - Dortmund), has finalised an equity transaction worth €7.4 million ($9.8 million) with Malaysian herbal-based products promoter, Biotropics Malaysia (Kuala Lumpur). The agreement “solidifies a minority stake held by Biotropics in IMD”, the German company reports. IMD will invest money raised by the equity transaction in the discovery and development of “further functional ingredients” and in its pharmaceutical pipeline. Biotopics will gain access to IMD’s natural product database and technology to identify, develop and market suitable natural active ingredients exclusively in key markets, including the US and Europe. IMD and Biotropics entered into a long-term strategic co-operation agreement in September last year ( Agrow No 553, p 6).



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts